Apogee Therapeutics
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immune (I&I) diseases with high unmet need.
Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment.
Our pipeline of differentiated antibody therapeutics targets well-established biological drivers and development pathways, with an initial focus on making impactful advancements in the treatment of atopic dermatitis and chronic obstructive pulmonary disease.
Wondering what you can expect? Our C.O.R.E. values not only embody who we are, but also guide every decision we make. If these resonate with you, we encourage you to apply!
We don’t want to do something just because that’s the way it’s always been done. We want to think differently about problems as they arise and our solutions towards them. We are curious and creative. We are always thinking how we can do things better, more efficiently. We refuse to stop at “good enough”.
The best thing we can do for our patients and each other is to create a psychologically safe environment. This requires checking our egos at the door. We trust each other, are comfortable debating, and believe regular and direct feedback is a gift. We make sure the best idea wins - not the loudest or most senior in the room - and we are able to disagree, but then commit, when necessary.
